RMMS is the only specialty litigation and counseling boutique in the United States devoted almost exclusively to the pharmaceutical industry, and our collective experience is second to none.
RMMS attorneys have litigated patents related to life sciences and pharmaceuticals for over 20 years, and thus, are well prepared to adjust to the changing biosimilars industry. Our team is well-versed in all aspects of the Biologics Price Competition and Innovation Act (BPCIA), and regularly guides clients through the complex provisions of the BPCIA as well as resulting litigation.
In addition, RMMS regularly counsels clients on regulatory issues related to the Hatch-Waxman Act and the BPCIA, including expedited FDA review strategies for drugs and biological products, patent listing and certification issues, product labeling, agency review requirements, risk management programs, marketing exclusivities, and citizen petitions.
RMMS continues to expand its biosimilar practice, including consulting and strategy development in advance of application filing, as well as our involvement in cutting-edge, first-of-of their kind court decisions related to biosimilar products.
Biologics HighlightsView All
More and more leaders in the life sciences industry are turning to RMMS for successful IP outcomes.
Here’s what they have to say.
Patent litigation specialist boutique Rakoczy Molino Mazzochi Siwik LLP has a stellar reputation for its work in the life sciences sphere.Legal 500
The RMMS team always keeps its client's end goal in mind and secures the best outcome for them.Chambers USA
Rakoczy Molino Mazzochi Siwik LLP has a highly-regarded Chicago-based life sciences practice. The team is known for its deep litigation experience assisting clients with patent validity, Hatch-Waxman, and IP infringement disputes. The team is further able to support clients on commercial matters including patent licensing and collaboration agreements.Chambers USA
Boutique firm much admired for its artful representation of generic pharmaceutical manufacturers in complex ANDA litigation. Other areas of strength include freedom-to-operate searches and licensing and collaboration agreements. Increasing bench strength sees it offer wider expertise beyond its traditional generics client base, bolstering its handling of brand mandates.Chambers USA
What's your biggest IP challenge?
The life sciences team at RMMS is ready to help.